Clinical trial · Observational
Comprehensive Segmental Revision System
NCT03270982CI-TRIAL-00114128active not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Clinical Data evaluation to document the performance and clinical outcomes of the Comprehensive Segmental Revision System.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Degenerative Disease | — | UNRESOLVED | — |
| Oncology | — | UNRESOLVED | — |
| Revision Surgery | — | UNRESOLVED | — |
| Rheumatoid Arthritis | — | UNRESOLVED | — |
| Trauma | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Comprehensive SRS Replacement | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Comprehensive SRS Replacement
- description
- Comprehensive SRS Device
- interventionNames
- Device: Comprehensive SRS Replacement
Primary outcomes (1)
- measure
- Implant survivorship assessed according to the implant revisions
- timeFrame
- 10 years
- description
- Implant survivorship assessed counting the number of implant revisions
Secondary outcomes (5)
- measure
- Clinical patient outcome measure: QuickDASH
- timeFrame
- Pre-operative and at 6 months, 1 year, 3 years and 5 years post-operative
- description
- The QuickDASH score will be used to measure physical function and symptoms of the upper limb in patients to be treated/treated with the Comprehensive SRS products.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Non Inflammatory Degenerative joint disease, including osteoarthritis, and avascular necrosis * Rheumatoid arthritis * Revision where other devices or treatments have failed * Correction of functional deformity * Oncology applications including bone loss due to tumour resection Exclusion Criteria: * Sepsis ( active) * Infection ( active) * Osteomyelitis (active)
References
Publications (0)
Data not yet available
No reference posted for this study.